MaxCyte MXCT Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about MaxCyte's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MaxCyte's equity method investments?
- MaxCyte (MXCT) reported equity method investments of $40.81M in Q1 2026.
- How has MaxCyte's equity method investments changed year-over-year?
- MaxCyte's equity method investments increased by 12.0% year-over-year, from $36.42M to $40.81M.
- What is the long-term trend for MaxCyte's equity method investments?
- Over 2 years (2023 to 2025), MaxCyte's equity method investments has grown at a 10.6% compound annual growth rate (CAGR), from $42.94M to $52.57M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.